missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human TUBE1 (aa 280-374) Control Fragment Recombinant Protein
Click to view available options
Cantidad:
100 μL
Unit Size:
100 microlitros
Description
Highest antigen sequence indentity to the following orthologs: Mouse (93%), Rat (93%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-56916 (PA5-56916. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Microtubules constitute one of the major components of eukaryotic cells cytoskeleton and are involved in many essential processes, including cell division, ciliary and flagellar motility and intracellular transport. Microtubules of the eukaryotic cytoskeleton are composed of a heterodimer of α- and β-tubulin. In addition to α- and β-tubulin, several other tubulins have been identified, bringing the number of distinct tubulin classes to seven. Most of these tubulins have distinct subcellular localization and an emerging, diverse set of functions.

Specifications
Especificaciones
Número de acceso | Q9UJT0 |
Concentración | ≥5.0 mg/mL |
Para utilizar con (aplicación) | Blocking Assay, Control |
Formulación | 1 M urea, PBS with no preservative; pH 7.4 |
ID de gen (Entrez) | 51175 |
Nombre | Human TUBE1 (aa 280-374) Control Fragment |
Cantidad | 100 μL |
Estado normativo | RUO |
Alias de gen | 2310061K05Rik; AI551343; dJ142L7.2; epsilon-tubulin; epsilon-tubulin 1; FLJ22589; FLJ44203; RP1-142L7.1; TUBE; Tube1; Tubulin; tubulin epsilon 1; tubulin epsilon chain; tubulin, epsilon 1 |
Nombre común | TUBE1 |
Mostrar más |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
Invitrogen™ Human TUBE1 (aa 280-374) Control Fragment Recombinant Protein >
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido